PHARMACOKINETICS AND SAFETY OUTCOMES OF GENERIC VERSUS BRANDED TESTOSTERONE PELLETS IN MEN WITH TESTOSTERONE DEFICIENCY: A SINGLE-CENTER, OPEN-LABEL, RANDOMIZED TRIAL.

被引：0

作者：

Kresch, Eliyahu ^{[1
]}

Molina, Manuel ^{[1
,2
]}

Lima, Thiago Fernandes Negris ^{[1
,2
]}

Gonzalez, Daniel ^{[3
]}

Ory, Jesse ^{[1
,2
]}

Reddy, Rohit ^{[1
,2
]}

Nackeeran, Sirpi ^{[3
]}

Ramasamy, Ranjith ^{[3
]}

机构：

[1] Univ Miami, Miami, FL USA

[2] Jackson Hlth Syst, Miami, FL USA

[3] Univ Miami, Miller Sch Med, Miami, FL 33136 USA

来源：

FERTILITY AND STERILITY | 2021年 / 116卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

P-559

引用

页码：E340 / E340

页数：1

共 50 条

[41] Pharmacokinetics and Safety of Eszopiclone in Healthy Chinese Volunteers Data from a Single-center, Open-label, Single and Multiple Dose, Randomized, Crossover Pharmacokinetic Study of Eszopiclone under Fasting Conditions
Wu, F.
Zhao, X. L.
Wei, M. J.
Wang, S. M.
Zhou, H.
Guo, S. J.
Zhang, P.
ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2012, 62 (12): : 561 - 565
[42] Comparison of zinc acetate hydrate and polaprezinc for zinc deficiency in patients on maintenance hemodialysis: A single-center, open-label, prospective randomized study
Okamoto, Teppei
Hatakeyama, Shingo
Konishi, Sakae
Okita, Kazutaka
Tanaka, Yoshimi
Imanishi, Kengo
Takashima, Tooru
Saitoh, Fumitada
Suzuki, Tadashi
Ohyama, Chikara
THERAPEUTIC APHERESIS AND DIALYSIS, 2020, 24 (05) : 568 - 577
[43] An open-label, phase 2, single centre, randomized, crossover design bioequivalence study of AndroForte 5 testosterone cream and Testogel 1% testosterone gel in hypogonadal men: study LP101
Wittert, G. A.
Harrison, R. W.
Buckley, M. J.
Wlodarczyk, J.
ANDROLOGY, 2016, 4 (01) : 41 - 45
[44] Pharmacokinetics and Safety of Subcutaneous Pasireotide and Intramuscular Pasireotide Long-acting Release in Chinese Male Healthy Volunteers: A Phase I, Single-center, Open-label, Randomized Study
Chen, Xia
Shen, Guoxiang
Jiang, Ji
Liu, Hongzhong
Hu, Ke
Darstein, Christelle
Lasher, Janet
Hu, Pei
CLINICAL THERAPEUTICS, 2014, 36 (08) : 1196 - 1210
[45] Allisartan Isoproxil Improves Endothelial Function and Vascular Damage in Patients with Essential Hypertension: A Single-Center, Open-Label, Randomized Controlled Trial
Gaoxing Zhang
Yongqiang Fan
Yumin Qiu
Zhe Zhou
Jianning Zhang
Zhichao Wang
Yuanya Liu
Xing Liu
Jun Tao
Advances in Therapy, 2020, 37 : 3551 - 3561
[46] Levetiracetam or Phenobarbitone as a First-Line Anticonvulsant in Asphyxiated Term Newborns? An Open-Label, Single-Center, Randomized, Controlled, Pragmatic Trial
Susnerwala, Sukena
Joshi, Amol
Deshmukh, Laxmikant
Londhe, Atul
HOSPITAL PEDIATRICS, 2022, 12 (07) : 647 - 653
[47] Temporomandibular joint disc repositioning and occlusal splint for adolescents with skeletal class II malocclusion: a single-center, randomized, open-label trial
Sun, Jiali
Zhu, Huimin
Lu, Chuan
Zhao, Jieyun
Nie, Xin
Yang, Zhi
He, Dongmei
BMC ORAL HEALTH, 2023, 23 (01)
[48] Temporomandibular joint disc repositioning and occlusal splint for adolescents with skeletal class II malocclusion: a single-center, randomized, open-label trial
Jiali Sun
Huimin Zhu
Chuan Lu
Jieyun Zhao
Xin Nie
Zhi Yang
Dongmei He
BMC Oral Health, 23
[49] A Single-Center Phase 2 Open-Label Trial Evaluating the Safety and Efficacy of Daratumumab in Treatment of Patients with Monoclonal Gammopathy of Renal Significance
Zand, Ladan
Rajkumar, S. Vincent
Sethi, Sanjeev
Leung, Nelson
Fervenza, Fernando C.
BLOOD, 2020, 136
[50] Allisartan Isoproxil Improves Endothelial Function and Vascular Damage in Patients with Essential Hypertension: A Single-Center, Open-Label, Randomized Controlled Trial
Zhang, Gaoxing
Fan, Yongqiang
Qiu, Yumin
Zhou, Zhe
Zhang, Jianning
Wang, Zhichao
Liu, Yuanya
Liu, Xing
Tao, Jun
ADVANCES IN THERAPY, 2020, 37 (08) : 3551 - 3561

← 1 2 3 4 5 →